Results 141 to 150 of about 1,231,953 (350)
What's New? Venous thromboembolism (VTE) is common in cancer patients, with direct oral anticoagulants, including rivaroxaban, recommended as first‐line therapy. However, oral anticoagulant use is limited due to the growing use of targeted therapy and concerns about drug‐drug interactions.
Esther M. Hollander +7 more
wiley +1 more source
From trials to programmatic scale-up: treatment outcomes of rifampicin-resistant tuberculosis during transition to short oral regimens in Vietnam (2021–2022) [PDF]
Nguyen Thi Mai Phuong +6 more
openalex +1 more source
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
K. Andries +17 more
semanticscholar +1 more source
Global patterns and trends in kidney cancer incidence and mortality
What's New? Decreasing mortality from kidney cancer in developed countries contrasts with persistently high or rising mortality in less‐developed regions. Factors underlying this widening gap remain incompletely understood. Using GLOBOCAN 2022 data, the present study examined patterns in kidney cancer incidence and mortality worldwide and the relation ...
Anton Barchuk +5 more
wiley +1 more source
What's New? Breast cancer is now the most common malignancy among women in sub‐Saharan Africa (SSA). Its impact on survivors’ quality of life and Global Health Status (GHS), however, remains inadequately studied in this setting. Here, using data from the African Breast Cancer‐Disparities in Outcomes (ABC‐DO) study, the authors examined GHS over time in
Shamsudeen Mohammed +10 more
wiley +1 more source
Prevalencia de sintomáticos respiratorios y tuberculosis en la población en condición de desplazamiento, Bucaramanga, 2007 [PDF]
Lilibeth López Moreno, Carlos Peña
openalex
This study develops an interpretable gradient‐boosting model that accurately identifies drug‐induced liver injury (DILI) using routine laboratory data. The model explains key clinical features through SHapley Additive exPlanations analysis and detects DILI earlier than expert evaluation, offering a transparent and practical tool for precision ...
Jingyi Ling +13 more
wiley +1 more source

